QS Investors, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2020$107,000
+28.9%
4,6000.0%0.00%0.0%
Q1 2020$83,000
-14.4%
4,6000.0%0.00%0.0%
Q4 2019$97,000
-17.8%
4,600
-28.7%
0.00%0.0%
Q3 2019$118,000
-48.7%
6,4500.0%0.00%
-50.0%
Q2 2019$230,000
+6.0%
6,4500.0%0.00%0.0%
Q1 2019$217,000
+1.9%
6,450
-0.2%
0.00%
-33.3%
Q4 2018$213,000
-89.4%
6,462
-80.4%
0.00%
-84.2%
Q3 2018$2,010,000
+24.8%
32,9650.0%0.02%
+18.8%
Q2 2018$1,610,000
+177.6%
32,965
+503.5%
0.02%
+166.7%
Q1 2018$580,000
+168.5%
5,462
+51.2%
0.01%
+200.0%
Q4 2017$216,000
+151.2%
3,612
+0.3%
0.00%
+100.0%
Q3 2017$86,000
+22.9%
3,6000.0%0.00%0.0%
Q2 2017$70,000
-17.6%
3,600
-0.7%
0.00%0.0%
Q1 2017$85,000
+8400.0%
3,626
+13846.2%
0.00%
Q4 2016$1,0000.0%260.0%0.00%
Q3 2016$1,0000.0%26
+44.4%
0.00%
Q2 2016$1,000
-99.8%
18
-99.9%
0.00%
-100.0%
Q4 2015$561,000
+53.7%
33,286
+0.1%
0.01%
+25.0%
Q3 2015$365,000
-13.1%
33,269
-0.9%
0.00%
-20.0%
Q2 2015$420,000
+13.5%
33,5580.0%0.01%
+25.0%
Q1 2015$370,000
-28.3%
33,558
+0.9%
0.00%
-33.3%
Q4 2014$516,00033,2690.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2018
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders